12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Advanced Cell Technology, International Stem Cell deal

Advanced Cell and International Stem Cell amended a 2004 deal to give ISCO an exclusive, worldwide license to Advanced Cell's IP covering parthenogenetically derived stem cells for use in generating human tissue. The original deal granted International Stem...

Read the full 167 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >